According to the report, the global AI-powered drug discovery market is likely to grow from USD 1 Billion in 2025 to USD 9.2 Billion in 2035 at a highest CAGR of 24.6% during the time period. The AI-powered drug discovery market is currently experiencing rapid growth because of three factors which include the need to shorten research and development timeframes and the increasing expenses of drug development processes and the requirement to enhance clinical trial success rates.
Pharmaceutical and biotechnology companies are now using AI-based platforms which help them analyze complicated biological and clinical and multi-omics data sets to improve their target identification and lead optimization and predictive modeling processes, which results in better accuracy and higher productivity and better decision-making abilities. The implementation of government programs together with public and private organization partnerships which focus on precision medicine and rare disease research will drive faster adoption of these technologies.
The biopharma sector uses artificial intelligence to create more efficient methods for molecule design and toxicity prediction and clinical candidate selection. The combination of artificial intelligence (AI) and machine learning (ML) with high-performance computing technology provides improved predictive capabilities and scalability for drug development processes.
The development of cloud-based artificial intelligence platforms together with generative models enables pharmaceutical researchers to conduct real-time simulations and virtual compound screenings, which leads to more efficient and affordable drug discovery processes that benefit healthcare systems worldwide.
Key Driver, Restraint, and Growth Opportunity Shaping the Global AI-Powered Drug Discovery Market
For instance, the Recursion Pharmaceuticals and Roche partnership expanded its AI-based research operations for target discovery and validation because both companies required AI technology to enhance their drug development operations.
The biological data complexity along with the fragmented genomic and proteomic and clinical record datasets creates ongoing challenges for research purposes. The existing data quality differences together with missing standardization and the challenges in verifying AI output results cause AI systems to experience problems with both scaling operations and achieving dependable performance.
The process of integrating AI technologies into conventional drug discovery methods requires organizations to invest in new infrastructure while acquiring special knowledge which results in higher operating expenses and delayed adoption of these technologies particularly for smaller biotech companies.
Artificial intelligence presents a significant opportunity in precision medicine and rare disease research because traditional research methods struggle to handle small patient groups and complicated disease patterns. AI technology allows researchers to discover new biomarkers and develop specific treatment methods at a faster speed. Schrödinger and other companies use AI-driven physics-based modeling to develop targeted therapies which create new possibilities for personalized medicine development and improve innovation capacity in areas that need it most.
Expansion of Global AI-Powered Drug Discovery Market
Technological Innovation, Biopharma Applications, and R&D Investments Driving the Global AI‑Powered Drug Discovery Market Expansion
Regional Analysis of Global AI-Powered Drug Discovery Market
Prominent players operating in global AI-powered drug discovery market include prominent companies such as Atomwise, Inc., BenevolentAI Limited, Berg LLC, BioXcel Therapeutics, Inc., Cyclica Inc., Deep Genomics Inc., Exscientia plc, Healx Limited, Iktos S.A., Insilico Medicine, Inc., Insitro, Inc., Lantern Pharma Inc., Numerate, Inc., Owkin, Inc., Recursion Pharmaceuticals, Inc., Schrödinger, Inc., Standigm Inc., Valo Health, Inc., Verge Genomics, Inc., XtalPi Inc., along with several other key players.
The global AI-powered drug discovery market has been segmented as follows:
Global AI-Powered Drug Discovery Market Analysis, by Offering
Global AI-Powered Drug Discovery Market Analysis, by Technology
Global AI-Powered Drug Discovery Market Analysis, by Drug Type
Global AI-Powered Drug Discovery Market Analysis, by Discovery Stage
Global AI-Powered Drug Discovery Market Analysis, by Therapeutic Area
Global AI-Powered Drug Discovery Market Analysis, by Deployment Mode
Global AI-Powered Drug Discovery Market Analysis, by Data Type
Global AI-Powered Drug Discovery Market Analysis, by Application
Global AI-Powered Drug Discovery Market Analysis, by End User
Global AI-Powered Drug Discovery Market Analysis, by Region
About Us
MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.
Contact Us
USA Address:
800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.
+1(302)303-2617
info@marketgenics.co
India Address:
3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.
sales@marketgenics.co
Table of Contents
Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography
We will customise the research for you, in case the report listed above does not meet your requirements.
Get 10% Free Customisation